Global Biologics and Biosimilars Sales Market Report 2021

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
The research shows that the growth of biologics industry may be slow but high profits during the period of patent may be attractive to newcomers.

Market Analysis and Insights: Global Biologics and Biosimilars Market
The global Biologics and Biosimilars market was valued at US$ 322440 in 2020 and will reach US$ 508830 million by the end of 2027, growing at a CAGR of 7.9% during 2022-2027.

Global Biologics and Biosimilars Scope and Market Size
The global Biologics and Biosimilars market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologics and Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others

Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others

The Biologics and Biosimilars market is analysed and market size information is provided by regions (countries). Segment by Application, the Biologics and Biosimilars market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee

Frequently Asked Questions